HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert Freedman Selected Research

beta-erythroidine

10/2008Olanzapine improves deficient sensory inhibition in DBA/2 mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert Freedman Research Topics

Disease

53Schizophrenia (Dementia Praecox)
01/2022 - 12/2002
8Infections
01/2022 - 08/2009
5Psychotic Disorders (Schizoaffective Disorder)
01/2022 - 01/2005
5Inflammation (Inflammations)
01/2022 - 01/2021
5Mental Disorders (Mental Disorder)
01/2021 - 04/2015
3Neurodevelopmental Disorders
01/2022 - 10/2019
3Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
06/2020 - 01/2016
3Autistic Disorder (Autism)
06/2020 - 01/2016
2Autism Spectrum Disorder
01/2022 - 12/2016
2Premature Birth (Birth, Premature)
01/2021 - 01/2018
2Virus Diseases (Viral Diseases)
01/2021 - 01/2020
2Obesity
01/2021 - 01/2021
2Respiratory Sounds (Crackle)
06/2020 - 01/2018
2Cognitive Dysfunction
05/2014 - 02/2010
1Substance-Related Disorders (Drug Abuse)
01/2022
1COVID-19
06/2020
1Marijuana Use
01/2020
1Neural Tube Defects (Exencephaly)
01/2018
1Alzheimer Disease (Alzheimer's Disease)
12/2016
1Cleft Palate (Palate, Cleft)
04/2015
1Anxiety Disorders (Anxiety Disorder)
06/2012
1Rupture
01/2012
1Wounds and Injuries (Trauma)
01/2012
1Pain (Aches)
04/2011
1Intellectual Disability (Idiocy)
03/2011
1Disease Susceptibility (Diathesis)
09/2008

Drug/Important Bio-Agent (IBA)

21Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2018 - 12/2002
16Choline (Choline Chloride)IBA
01/2022 - 02/2010
10Biological ProductsIBA
12/2019 - 06/2004
10NicotineFDA Link
08/2013 - 06/2004
7Cholinergic ReceptorsIBA
01/2020 - 02/2010
6Cholinergic Agents (Cholinergics)IBA
04/2015 - 06/2004
6Antipsychotic Agents (Antipsychotics)IBA
01/2014 - 02/2003
5Nicotinic AgonistsIBA
01/2018 - 06/2006
5Pharmaceutical PreparationsIBA
12/2016 - 07/2005
4Folic Acid (Vitamin M)FDA LinkGeneric
01/2022 - 04/2015
4Phosphatidylcholines (Phosphatidylcholine)IBA
01/2021 - 04/2015
4alpha7 Nicotinic Acetylcholine ReceptorIBA
04/2009 - 12/2002
3Vitamin DFDA LinkGeneric
01/2022 - 06/2020
3VitaminsIBA
01/2022 - 01/2018
3MicronutrientsIBA
01/2022 - 01/2018
3C-Reactive ProteinIBA
01/2021 - 01/2019
3Acetylcholine (Acetylcholine Chloride)FDA Link
01/2020 - 07/2007
3Biomarkers (Surrogate Marker)IBA
05/2014 - 01/2005
2CytokinesIBA
01/2021 - 10/2019
2Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
06/2020 - 01/2018
2SmokeIBA
11/2011 - 06/2006
2Tropisetron (Navoban)IBA
11/2005 - 07/2005
1Sp4 Transcription FactorIBA
01/2022
1Glutamate Receptors (Glutamate Receptor)IBA
01/2022
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2021
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2021
1Phosphotransferases (Kinase)IBA
10/2019
1LipidsIBA
10/2019
1Phosphatidylinositols (Phosphatidylinositol)IBA
10/2019
1Delayed-Action PreparationsIBA
01/2018
1HLA-A Antigens (HLA-A)IBA
08/2013
1ButyrophilinsIBA
08/2013
1Antidepressive Agents (Antidepressants)IBA
06/2012
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
02/2012
1Glutamic Acid (Glutamate)FDA Link
09/2011
1Type II Vasoactive Intestinal Peptide ReceptorsIBA
03/2011
1ChromatinIBA
08/2009
1Histones (Histone)IBA
08/2009
1beta-erythroidineIBA
10/2008
1Olanzapine (Zyprexa)FDA Link
10/2008
1nicotinic receptor alpha4beta2IBA
10/2008
1Bungarotoxins (alpha-Bungarotoxin)IBA
10/2008
1CateninsIBA
09/2008
1Varenicline (Chantix)FDA Link
08/2007
1NucleotidesIBA
07/2007
13-(2,4-dimethoxybenzylidene)anabaseineIBA
01/2007
1gamma-Aminobutyric Acid (GABA)IBA
06/2004
1Clozapine (Clozaril)FDA LinkGeneric
02/2003
1Haloperidol (Haldol)FDA LinkGeneric
02/2003

Therapy/Procedure

1Self Medication
11/2007